AGP Picks
View all

Alternative Medicine Times
Provided by AGP

Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 2, 2026

AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 2041
Sep. 2, 2026

AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 2041

Indeterminate GlobeNewswire
AiM Medical Robotics Awarded $2 Million National Cancer Institute Grant to Advance MRI-Guided Robotic Treatment of Brain Cancer
Sep. 2, 2026

AiM Medical Robotics Awarded $2 Million National Cancer Institute Grant to Advance MRI-Guided Robotic Treatment of Brain Cancer

Indeterminate GlobeNewswire
Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference
Sep. 2, 2026

Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference

Indeterminate GlobeNewswire
Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker 
Sep. 2, 2026

Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker 

Indeterminate GlobeNewswire
MannKind to Present at Upcoming Investor Conferences
Sep. 2, 2026

MannKind to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
Sep. 2, 2026

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September

Indeterminate GlobeNewswire
RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th
Sep. 2, 2026

RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th

Indeterminate GlobeNewswire
Equillium to Participate in Upcoming Investor Conferences
Sep. 2, 2026

Equillium to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer
Sep. 2, 2026

SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer

Indeterminate GlobeNewswire
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange
Sep. 2, 2026

ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange

Indeterminate GlobeNewswire
Caring Brands Inc. (Nasdaq: CABR) Completes Initial $4.6 Million Closing Under Ongoing $9 Million Private Placement
Sep. 2, 2026

Caring Brands Inc. (Nasdaq: CABR) Completes Initial $4.6 Million Closing Under Ongoing $9 Million Private Placement

Indeterminate GlobeNewswire
Temenos and Celent: American Banks Face Growing Fight for the 'Switchable Middle'
Sep. 2, 2026

Temenos and Celent: American Banks Face Growing Fight for the 'Switchable Middle'

Indeterminate GlobeNewswire
100 years of better courts and better tennis: Laykold®, an AstroTurf Company, returns as Official Surface of the US Open
Sep. 2, 2026

100 years of better courts and better tennis: Laykold®, an AstroTurf Company, returns as Official Surface of the US Open

Indeterminate GlobeNewswire
SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
Sep. 2, 2026

SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies

Indeterminate GlobeNewswire
Akribis Veins & Vitality Expands Non-Surgical Facial Rejuvenation Options for Patients Seeking Natural-Looking Results
Sep. 2, 2026

Akribis Veins & Vitality Expands Non-Surgical Facial Rejuvenation Options for Patients Seeking Natural-Looking Results

Indeterminate EIN Presswire
R3 Life Wellness Brings Mindful Movement and Longevity Together at ANAPANA SATI
Sep. 2, 2026

R3 Life Wellness Brings Mindful Movement and Longevity Together at ANAPANA SATI

Indeterminate EIN Presswire
GYMNATION TURNS OUT THE LIGHTS WITH 'DANS LE NOIR: CLASS IN THE DARK'
Sep. 2, 2026

GYMNATION TURNS OUT THE LIGHTS WITH 'DANS LE NOIR: CLASS IN THE DARK'

Indeterminate EIN Presswire
ProQR to Participate in Upcoming Investor Conferences in September 2026
Sep. 2, 2026

ProQR to Participate in Upcoming Investor Conferences in September 2026

Indeterminate GlobeNewswire
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September
Sep. 2, 2026

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September

Indeterminate GlobeNewswire
SpyGlass Pharma to Participate in Upcoming Investor Conferences
Sep. 2, 2026

SpyGlass Pharma to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Alternative Medicine Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.